ROBERT KEETER: Open Payments
NPI 1134751738 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,331 in 78 payments from 17 companies in 2025. Trend: 2023 $1,606 · 2024 $1,481 · 2025 $1,331
Food & beverage: $1,331
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $229 |
| Novo Nordisk Inc | 13 | $200 |
| Lilly USA, LLC | 12 | $181 |
| AstraZeneca Pharmaceuticals LP | 8 | $153 |
| Otsuka America Pharmaceutical, Inc. | 6 | $101 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| Amgen Inc. | 4 | $64 |
| Lundbeck LLC | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Exact Sciences Corporation | 2 | $40 |
Products named: REXULTI, MOUNJARO, QULIPTA, FARXIGA, Wegovy, JARDIANCE, TRELEGY ELLIPTA, VRAYLAR.
Industry payments across NC — which companies pay providers there.
